Helios Technologies, Inc. (HLIO) Stock Analysis
Is HLIO a good investment?
Helios Technologies, Inc. (HLIO) has a Plutrex AI rating of 52.0/100 as of November 12, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: D/E ratio of 0.36 is 36% below industry average of 0.563, with FCF of $120.7M providing genuine capital allocation flexibility — supports dividends, buybacks, and M&A without financial stress. Main concern: ROE of 8.47% is 62.5% below industry average of 22.56% — this is a structural capital efficiency deficit, not a cyclical issue; paying P/E 20.44x for a business generating sub-10% ROE means capital is being destroyed relative to peers, and analyst consensus target of $50.50 implies only 5.1% upside with no margin of safety.
Investment Summary
Helios Technologies (HLIO) at $48.06 is a structurally challenged industrial machinery company that has seen its stock collapse 29% from $67.65 and analyst targets slashed 23% from $65.50 to $50.50 — implying only 5.1% upside from current levels. The company trades at P/E 20.44x with a PEG of 1.41x against 5-year EPS growth of 14.5%, which is a 44% discount to the industry PEG of 2.54x — but this discount is earned, not mispriced. The core problem: ROE of 8.47% is a catastrophic 62.5% below the industry average of 22.56%, net margins of 8.74% trail peers by 30.6%, and revenue growth of 4.3% is 70% below the industry's 14.5%. The bright spots are real but insufficient: D/E of 0.36 (36% below peers), FCF of $120.7M, and record Q3 sales of $230M (+4% YoY) with a raised full-year revenue outlook. The news is genuinely positive with a 94.5/100 sentiment score and earnings beats, but it confirms a steady, unspectacular operator — not a turnaround or breakout story. At $50.50 analyst consensus, there is no meaningful upside cushion. This is a Hold/Weak Hold situation where the right entry for a Buy would require the stock at $42-44 to build in adequate margin of safety.
Key Strengths
- D/E ratio of 0.36 is 36% below industry average of 0.563, with FCF of $120.7M providing genuine capital allocation flexibility — supports dividends, buybacks, and M&A without financial stress
- Record Q3 2026 sales of $230M (+4% YoY) with raised full-year revenue outlook demonstrates operational consistency and execution reliability despite supply chain pressures
- PEG ratio of 1.41x vs industry 2.54x (44.4% discount) means investor is not overpaying relative to 5-year EPS growth of 14.5% — cheapest stock on PEG basis within peer group
Key Concerns
- ROE of 8.47% is 62.5% below industry average of 22.56% — this is a structural capital efficiency deficit, not a cyclical issue; paying P/E 20.44x for a business generating sub-10% ROE means capital is being destroyed relative to peers, and analyst consensus target of $50.50 implies only 5.1% upside with no margin of safety
- Revenue growth of 4.3% vs industry 14.5% (a 70% shortfall) means HLIO is losing competitive ground structurally; stock has already collapsed 29% from $67.65 and analyst targets have been cut 23%, signaling continued fundamental reassessment rather than a bottoming signal
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
HLIO's fundamentals reflect a solid but unexceptional industrial business. Gross margin of 30.18% (vs industry 32.80%) and operating margin of 13.14% (vs industry 15.27%) show consistent underperformance at every margin line. Net margin of 8.74% is 30.6% below the industry average of 12.60%. The most damning metric remains ROE of 8.47% vs industry 22.56% — HLIO generates less than 40 cents of return per dollar of equity for every dollar its average peer generates. Revenue growth of only 4.3% (industry 14.5%) confirms the top-line is not a source of competitive advantage. On the positive side, D/E of 0.36 (industry 0.563) reflects disciplined balance sheet management, and FCF of $120.7M provides genuine cash backing for earnings. P/E of 20.44x (industry 24.51x, a 16.6% discount) and PEG of 1.41x (industry 2.54x, a 44.4% discount) appear cheap but are justified by the structural quality deficit. Five-year forward EPS growth of 14.5% is respectable but only marginally below the industry's 15.2%. The intrinsic value range using conservative DCF (14.5% growth decelerating to 8% terminal, 10% discount rate) suggests $44-52 fair value, placing current price of $48.06 near the midpoint — neither cheap nor expensive.
News Sentiment
Helios Technologies is quietly executing — but quiet execution may not be enough to excite investors. The Florida-based industrial technology company delivered record third-quarter sales of $230 million, up 4% from the same period last year, and promptly raised its full-year 2026 revenue outlook. CEO Sean Bagan and CFO Jeremy Evans highlighted the company's ability to navigate supply chain pressures through strong operational discipline — no small feat in today's industrial environment. The Q3 2026 Earnings Call Transcript and subsequent analyst notes confirmed HLIO beat both earnings and revenue estimates for the quarter, with key metrics showing operational consistency. Yet the market's response tells a different story: the stock has fallen nearly 29% over the past two weeks from $67.65, reflecting a fundamental reassessment of what this business is worth. The beat-and-raise narrative — normally a catalyst for a pop — was met with muted enthusiasm because investors are grappling with a harder question: is a company growing revenues at 4% per year, generating a return on equity of less than 9%, worth paying 20 times earnings for? The headlines are positive, but the story underneath reveals a steady, reliable industrial manufacturer that may need to prove it can accelerate growth before the stock sustainably recovers.
Risk Assessment
PRIMARY RISK: Continued multiple compression — at P/E 20.44x on ROE 8.47%, the stock still trades at a quality premium it hasn't earned. If forward EPS estimates of 9.5% for next year disappoint, P/E could compress to 17-18x, implying $40-42 downside. SECONDARY RISK: Revenue growth of 4.3% is structurally weak; any macro headwind to industrial end markets could push this into revenue decline territory given the thin top-line momentum. TERTIARY RISK: Analyst target trajectory has been consistently downward ($95 → $65.50 → $50.50), creating a risk of further cuts that drag the stock below current levels. MITIGATION: D/E of 0.36 and FCF of $120.7M provide real downside protection through dividends and buybacks. Entry only at $42-45 zone provides ~10% discount to current price and builds in margin of safety at P/E ~18-19x — more appropriate for HLIO's ROE profile. Stop at $39 limits downside to ~10% from entry midpoint.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is HLIO a halal stock?
No, Helios Technologies, Inc. (HLIO) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for HLIO?
Helios Technologies, Inc. (HLIO) has a Plutrex AI rating of 52.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is HLIO a good investment?
According to Plutrex AI, HLIO has a Hold rating (52.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in HLIO?
US stocks like HLIO can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in HLIO?
Plutrex AI identifies the main risks for HLIO by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.